Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

A man had an allergic reaction to minoxidil, which stopped after he discontinued use and started corticosteroids.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Taking Propecia might lead to the development of cataracts.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Stressed fibroblasts greatly increase melanin production in hair, skin, and eye cells, mainly due to a growth factor called bFGF.

Melatonin stimulates the skin components of ram's scrotum during their non-breeding season.

Consider NF1 in newborns with rare congenital anomalies.

Skin reactions from cancer treatments might predict how well the treatments work.

Darker hair in guinea pigs holds more codeine than lighter hair.

Plant-derived nanovesicles show promise for treating skin issues like hair loss and aging.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Proton minibeam radiotherapy shows promise for sparing healthy tissue in cancer treatment but needs further research and technological development.

EGFR helps control how hair grows and forms without needing p53 protein.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

ALKBH5 helps wounds heal faster by stabilizing PELI2 mRNA.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

3D bioprinting offers new ways to treat head and neck defects with bioinks that mimic natural tissues.

Maintaining natural oxygen levels is crucial for healthy skin cells and effective treatments.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

Bacterial cellulose is a promising material for biomedical uses but needs improvements in antimicrobial properties and degradation rate.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Targeting LGR4 may help treat cancer by reducing cancer stem cell traits and drug resistance.

RORA may help regulate hair growth by affecting hair follicle stem cells.